SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-138137
Filing Date
2020-12-21
Accepted
2020-12-21 17:19:17
Documents
7
Period of Report
2020-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2038916d1_6k.htm 6-K 13084
2 EXHIBIT 99.1 tm2038916d1_ex99-1.htm EX-99.1 63416
3 EXHIBIT 99.2 tm2038916d1_ex99-2.htm EX-99.2 973630
4 EXHIBIT 99.3 tm2038916d1_ex99-3.htm EX-99.3 648988
5 EXHIBIT 99.4 tm2038916d1_ex99-4.htm EX-99.4 983761
6 GRAPHIC tm2038916d1_ex99-1img03.jpg GRAPHIC 4734
7 GRAPHIC tm2038916d1_ex99-1img04.jpg GRAPHIC 3607
  Complete submission text file 0001104659-20-138137.txt   2695711
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 201405105
SIC: 2833 Medicinal Chemicals & Botanical Products